NCT06660563
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06660563
Title A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | ESP | AUS

Facility Status City State Zip Country Details
Concord Hospital Concord 2139 Australia Details
St Vincents Hospital Melbourne Fitzroy 3065 Australia Details
Macquarie University Hospital North Ryde 2109 Australia Details
Hosp Univ Vall D Hebron Barcelona 08035 Spain Details
Hosp. Clinic de Barcelona Barcelona 08036 Spain Details
Inst. Cat. Doncologia-H Duran I Reynals L'Hospitalet de Llobregat 08908 Spain Details
Hosp. Gral. Univ. Gregorio Maranon Madrid 28007 Spain Details
Hosp. Univ. 12 de Octubre Madrid 28041 Spain Details
China Medical University Hospital Taichung 40447 Taiwan Details
National Taiwan University Hospital Taipei 100 Taiwan Details
University Hospitals Of Leicester Nhs Trust Leicester Le1 5ww United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field